VIMAL PATEL: Open Payments
NPI 1427198787 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,232 in 91 payments from 18 companies in 2025. Trend: 2023 $2,392 · 2024 $2,343 · 2025 $2,232
Food & beverage: $2,232
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $488 |
| Novo Nordisk Inc | 9 | $220 |
| ABBVIE INC. | 9 | $200 |
| Indivior Inc. | 6 | $163 |
| Lilly USA, LLC | 7 | $161 |
| Dexcom, Inc. | 6 | $158 |
| Exact Sciences Corporation | 5 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $119 |
| Verona Pharma, Inc. | 4 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
Products named: AIRSUPRA, SUBLOCADE, Dexcom G6 Transmitter, MOUNJARO, Cologuard Collection Kit, FARXIGA, CAPLYTA, BREZTRI.
Industry payments across MA — which companies pay providers there.
